Target RWE

Biotechnology ResearchUnited States51-200 Employees

Target RWE's acquisition by Highlander Health in January 2025 is enabling the use of real-world, longitudinal data to modernize clinical evidence generation.  We partner with leading health systems and KOLs around the US and build real-world data products for high-value use cases.  We also deeply collaborate with our research partners to apply principled epidemiological methods for uncovering deep insights on medical need, disease progression, and the efficacy and safety of treatments in the real-world setting.  

Our multi-stakeholder model also allows us to launch prospective studies to tackle challenging use cases that retrospective data alone cannot solve.  These fully integrated capabilities streamline and consolidate evidence generation methods and widen what can be accomplished in the real-world setting.  Today we're focused on hepatology, gastroenterology, and dermatology but will soon be expanding the breadth of our products and services.  

Stay tuned for updates!

Sign up for free to view info

Email Format Employee directory